These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 1981530)
21. Identification of urinary metabolites of orally administered N,N-dimethyl-p-toluidine in male F344 rats. Kim NC; Ghanbari K; Kracko DA; Weber WM; McDonald JD; Dix KJ J Toxicol Environ Health A; 2007 May; 70(10):781-8. PubMed ID: 17454554 [TBL] [Abstract][Full Text] [Related]
22. Characterization of metabolites and disposition of tertiary amyl methyl ether in male F344 rats following inhalation exposure. Sumner SC; Asgharian B; Moore TA; Parkinson HD; Bobbitt CM; Fennell TR J Appl Toxicol; 2003; 23(6):411-7. PubMed ID: 14635265 [TBL] [Abstract][Full Text] [Related]
23. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man. Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788 [TBL] [Abstract][Full Text] [Related]
25. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
26. Metabolism of (R)-(+)-menthofuran in Fischer-344 rats: identification of sulfonic acid metabolites. Chen LJ; Lebetkin EH; Burka LT Drug Metab Dispos; 2003 Oct; 31(10):1208-13. PubMed ID: 12975329 [TBL] [Abstract][Full Text] [Related]
27. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy. Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078 [TBL] [Abstract][Full Text] [Related]
28. The metabolism and excretion of carbovir, a carbocyclic nucleoside, in the rat. Walsh JS; Patanella JE; Unger SE; Brouwer KR; Miwa GT Drug Metab Dispos; 1990; 18(6):1084-91. PubMed ID: 1981517 [TBL] [Abstract][Full Text] [Related]
29. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone. Prakash C; Kamel A; Anderson W; Howard H Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052 [TBL] [Abstract][Full Text] [Related]
31. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects. Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733 [TBL] [Abstract][Full Text] [Related]
32. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog. Wong BK; Woolf TF; Chang T; Whitfield LR Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548 [TBL] [Abstract][Full Text] [Related]
33. Excretion and identification of methacrylonitrile metabolites in the bile of male F344 rats. Ghanayem BI; Burka LT Drug Metab Dispos; 1996 Apr; 24(4):390-4. PubMed ID: 8801052 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Takayama F; Iwasawa Y; Saito K; Shiratori K; Ohtawa M Xenobiotica; 1989 Dec; 19(12):1407-20. PubMed ID: 2618091 [TBL] [Abstract][Full Text] [Related]
35. Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates. Thomassen D; Pearson PG; Slattery JT; Nelson SD Drug Metab Dispos; 1991; 19(5):997-1003. PubMed ID: 1686249 [TBL] [Abstract][Full Text] [Related]
36. In vivo metabolism of the leukotriene receptor antagonist, 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid (SK&F 102,081) in the guinea pig. Newton JF; Straub KM; Kuo GY; Perchonock CD; McCarthy ME; Gleason JG; Lynn RK Drug Metab Dispos; 1987; 15(2):168-76. PubMed ID: 2882973 [TBL] [Abstract][Full Text] [Related]
37. Isolation and identification of major urinary metabolites of rifabutin in rats and humans. Utkin I; Koudriakova T; Thompson T; Cottrell C; Iatsimirskaia E; Barry J; Vouros P; Gerber N Drug Metab Dispos; 1997 Aug; 25(8):963-9. PubMed ID: 9280404 [TBL] [Abstract][Full Text] [Related]
38. Metabolic fate of [3H]-l-menthol in the rat. Yamaguchi T; Caldwell J; Farmer PB Drug Metab Dispos; 1994; 22(4):616-24. PubMed ID: 7956738 [TBL] [Abstract][Full Text] [Related]
39. Detection of glutathione conjugates derived from 4-ipomeanol metabolism in bile of rats by liquid chromatography-tandem mass spectrometry. Alvarez-Diez TM; Zheng J Drug Metab Dispos; 2004 Dec; 32(12):1345-50. PubMed ID: 15328249 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of the experimental antitumor agent acridine carboxamide in the mouse. Robertson IG; Palmer BD; Paxton JW; Bland TJ Drug Metab Dispos; 1993; 21(3):530-6. PubMed ID: 8100511 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]